Sirius Medical key facts
- Developer of a tumor localization technology designed to improve care for cancer patients.
- It has raised $28.1M; the latest was Later Stage VC ($10.3M) in Feb 2025.
- Notable investors include Brabantse Ontwikkelings Maatschappij, Invest-NL (Investment Company), Holland Capital (Private Equity), Rotrip Europe, Curie Capital — 13 tracked in total.
- Status: Privately Held (backing).
Who backs Sirius Medical
13+Membership and data by Private Market View
- ·The complete investor list: 13 names
- ·Watch Sirius Medical: the Monday email on marks, rounds and moves
Sirius Medical funding rounds
No funding rounds for Sirius Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Sirius Medical investors
13 investors are on record for Sirius Medical, including Brabantse Ontwikkelings Maatschappij, Invest-NL (Investment Company), Holland Capital (Private Equity) and Rotrip Europe.
About Sirius Medical
Developer of a tumor localization technology designed to improve care for cancer patients. The company's technology uses a tiny implanted magnetic seed to precisely mark the tumor and a detection probe to accurately locate the seed during surgery, enabling patients to receive affordable cancerous tumor surgery and improved surgical care.
- Sector
- Healthcare
- HQ
- Eindhoven, Netherlands
- Founded
- 2017
- Employees
- 50
- Website
- sirius-medical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Sirius Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.